Nephrocare Health Services Limited
All news and filings related to Nephrocare Health Services Limited.
View all news & filings- Low impact
Nephroplus Closes Trading Window from April 1, 2026, for Audited Financial Results
Nephrocare Health Services Limited (NEPHROPLUS) will close its trading window from April 01, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026, in compliance with SEBI regulations.
Read the summary - Low impact
Nephrocare Health Services to attend Investor Conference on March 23, 2026
Nephrocare Health Services Limited will attend an investor conference on March 23, 2026. The company will hold a 1*1 meeting with Dam Capital Conference Group in Mumbai. Discussions will be limited to publicly available information.
Read the summary - Low impact
Nephroplus to Meet Investors/Analysts on Feb 24, 2026
Nephrocare Health Services Limited will hold meetings with investors and analysts on February 24, 2026. These meetings will be based on publicly available information only, with no UPSI to be discussed. The company may update the schedule as needed.
Read the summary - Low impact
Nephrocare Health Services to attend IIFL Conference on Feb 24, 2026
Nephrocare Health Services Limited will participate in an investor conference hosted by IIFL Conference Group on February 24, 2026. The one-on-one meeting in Mumbai will focus on publicly available information, with no unpublished price-sensitive information to be discussed.
Read the summary - High impact
NephroPlus Q3 FY26 Earnings Call Transcript Released; Company Highlights Growth Drivers
NephroPlus released its Q3 & 9-month FY26 earnings call transcript. Revenue grew 32% YoY in Q3 and 37% in 9 months. Adjusted PAT increased 71% in Q3 and 103% in 9 months. The company targets 15%-20% revenue CAGR over 3-4 years, driven by domestic and international expansion. International revenues now form 41% of the total.
Read the summary - Medium impact
Nephroplus Subsidiary Acquires Philippine Dialysis Center for PHP 49.4 Million
Nephrocare Health Services Limited's subsidiary in the Philippines is acquiring a dialysis center. The acquisition is for PHP 49.4 million through an Asset Transfer Agreement dated February 12, 2026.
Read the summary - Low impact
Nephroplus Q3FY26 Monitoring Report: IPO Proceeds Utilization Reviewed
Nephrocare Health Services Limited's Monitoring Agency Report for Q3FY26 confirms IPO proceeds utilization. ₹904.99 million was used for borrowing repayment in the quarter. Unutilized proceeds stand at ₹2,629.06 million, largely held in fixed deposits. The report covers the utilization of ₹3,534.05 million IPO proceeds for new clinics, debt repayment, and general corporate purposes.
Read the summary - Low impact
Nephroplus Q3 FY26 Investor Call Audio Recording Available
Nephrocare Health Services Limited released the audio recording of its investor conference call held on February 11, 2026. The call focused on the Q3 and nine months ended December 31, 2025, financial results. The recording is available on the company website.
Read the summary - High impact
NephroPlus Q3 FY26 Results: Revenue up 31.7% YoY to ₹259.7 Cr, Adj. EBITDA up 43.0% YoY to ₹63.1 Cr
NephroPlus reported Q3 FY26 revenue of ₹259.7 crore, up 31.7% YoY. For 9M FY26, revenue was ₹733.2 crore, up 36.6% YoY. Adjusted EBITDA for Q3 FY26 increased 43.0% YoY to ₹63.1 crore, and for 9M FY26, it rose 52.1% YoY to ₹175.4 crore. Treatment volumes grew 17.7% in Q3, with international revenue contribution rising to 41.1%.
Read the summary - High impact
NephroPlus Q3 FY26 Revenue Surges 31.7% YoY to ₹259.7 Cr; Adj. EBITDA up 43%
NephroPlus reported Q3 FY26 revenue of ₹259.7 crore, up 31.7% YoY. Nine-month FY26 revenue was ₹733.2 crore, up 36.6% YoY. Adjusted EBITDA grew 43.0% YoY to ₹63.1 crore in Q3 FY26. Adjusted PAT increased 71.3% YoY to ₹34.4 crore in Q3 FY26. The company is Asia's largest dialysis network.
Read the summary - Medium impact
Nephroplus Reports Q3 FY26 Results: Profit Rises to ₹84.52 Crore, Appoints Ravindra Tiwari to Senior Management
Nephrocare Health Services Limited reported its Q3 FY26 results. Standalone profit for the quarter was ₹84.52 crore, a turnaround from the previous quarter's loss. Consolidated profit for the quarter stood at ₹322.40 crore. The company also appointed Mr. Ravindra Tiwari as Senior Management Personnel, effective February 10, 2026.
Read the summary - Medium impact
Nephroplus Declares Q3 FY26 Results; Appoints Ravindra Tiwari to Senior Management
Nephrocare Health Services Limited reported its Q3 FY26 results. The company appointed Mr. Ravindra Tiwari as Senior Management Personnel. Mr. Tiwari brings over 18 years of experience in internal audit and governance.
Read the summary - Low impact
Nephroplus Shareholders Approve Re-appointment of Director and Secretarial Auditor via Postal Ballot
Nephrocare Health Services Limited shareholders approved the re-appointment of Mr. Om Prakash Manchanda as Independent Director and the appointment of M/s Makarand M. Joshi & Co. as Secretarial Auditor through a postal ballot. The remote e-voting concluded on February 06, 2026.
Read the summary - Low impact
Nephrocare Health Services Schedules Q3FY26 Earnings Call for Feb 11, 2026
Nephrocare Health Services Limited will hold its Q3FY26 Earnings Call on February 11, 2026, at 4:00 PM IST. The call will discuss unaudited financial results for the quarter and nine months ended December 31, 2025. Key management personnel will participate.
Read the summary - Medium impact
Nephroplus Subsidiary Acquires Dialysis Center in Philippines for PHP 37.72 Million
Nephrocare Health Services Limited's subsidiary, Nephrocare Health Care Services, Philippines Inc., acquired a dialysis center in Cauayan, Philippines. The transaction involved an Asset Transfer Agreement with Dialysis Center of Cauayan Inc. for PHP 37,721,600. A joint operation agreement is in place pending license transfer.
Read the summary - Medium impact
Nephroplus Approves USD 6 Million Corporate Guarantee for Philippines Subsidiary
Nephrocare Health Services Limited's board approved a Corporate Guarantee of up to USD 6 million for its Philippines subsidiary. This guarantee aims to secure working capital facilities for Nephrocare Health Care Services Philippines Inc. The approval was granted during a board meeting on January 15, 2026. The guaranteed amount will be a contingent liability.
Read the summary - Low impact
Nephrocare Health Services Files SEBI Compliance Certificate for Q3 FY26
Nephrocare Health Services Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The company's Registrar and Share Transfer Agent, KFIN Technologies Limited, confirmed that details of securities dematerialized/rematerialized were furnished to stock exchanges.
Read the summary - Low impact
Nephrocare Health Services Limited Changes Corporate Identification Number (CIN)
Nephrocare Health Services Limited's Corporate Identification Number (CIN) has been changed by the Ministry of Corporate Affairs from U85100TG2009PLC066359 to L85100TG2009PLC066359. This update follows the company's listing on the BSE and NSE.
Read the summary - Low impact
Nephrocare Health Services Limited: Newspaper Publication on Postal Ballot Intimation
Nephrocare Health Services Limited announced newspaper publications regarding postal ballot intimation and remote e-voting details. The e-voting period is from January 8, 2026, to February 6, 2026. The results will be published on the company website and communicated to stock exchanges.
Read the summary - Low impact
Nephroplus initiates Postal Ballot for Director Re-appointment and Secretarial Auditor Appointment
Nephrocare Health Services Limited is conducting a postal ballot via remote e-voting to re-appoint Mr. Om Prakash Manchanda as Independent Director for a second three-year term (Feb 11, 2026 - Feb 10, 2029). Additionally, M/s Makarand M. Joshi & Co. is proposed as Secretarial Auditor for FY26-FY30. E-voting runs from Jan 8 to Feb 6, 2026.
Read the summary - Low impact
Nephroplus Initiates Postal Ballot for Director Re-appointment and Auditor Appointment
Nephrocare Health Services Limited is conducting a postal ballot for shareholders to vote on the re-appointment of Mr. Om Prakash Manchanda as Independent Director and the appointment of M/s Makarand M. Joshi & Co. as Secretarial Auditor. Remote e-voting is open from January 8, 2026, to February 6, 2026.
Read the summary - Low impact
Nephroplus Reappoints Om Prakash Manchanda as Independent Director
Nephrocare Health Services Limited's Board approved the reappointment of Mr. Om Prakash Manchanda as Independent Director for three years from February 11, 2026. M/s Makarand M. Joshi & Co. was appointed as Secretarial Auditor for five years from April 1, 2025. Both appointments require shareholder approval.
Read the summary - Low impact
Nephrocare Health Services: Trading Window Closed from Dec 31, 2025
Nephrocare Health Services Limited will close its trading window from December 31, 2025. The window will reopen 48 hours after the declaration of unaudited financial results for the quarter and nine months ended December 31, 2025. This is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Read the summary - Low impact
Nephrocare Health Services Appoints Kishore Kathri as Company Secretary and Compliance Officer
Nephrocare Health Services Limited has appointed Mr. Kishore Kathri as Company Secretary and Compliance Officer, effective July 16, 2025. Mr. Kathri brings over 12 years of experience in corporate governance and regulatory compliance.
Read the summary - Low impact
Nephroplus Updates Code for Fair Disclosure of Unpublished Price Sensitive Information
Nephrocare Health Services Limited has updated its Code of Practices and Procedures for Fair Disclosure of UPSI and framed Operating Guidelines for sharing such information. The guidelines detail legitimate purposes, recipient information, notice requirements, and secure sharing methods, including NDAs and VDRs. These are subject to annual review.
Read the summary - Low impact
Nephroplus Authorizes Key Officials for Materiality Assessment and Disclosure
Nephrocare Health Services Limited has authorized its Managing Director, CEO, CFO, and Company Secretary to assess and disclose material events. This includes Mr. Vikram Vuppala, Mr. Rohit Singh, Mr. Prashant Vinodkumar Goenka, and Mr. Kishore Kathri, as per SEBI regulations.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio